133 related articles for article (PubMed ID: 33466200)
1. Optimal intervention time and risk of the activating blood and removing stasis method in acute cerebral hemorrhage patients: A randomized placebo-controlled trial.
Ma Y; Zhang D; Lv Z; Cui Y; Fei Y; Chang T; Yu M; Lu J; Huang Q; Zhang Y; Xu P; Lan T; Wang J
Medicine (Baltimore); 2021 Jan; 100(2):e24214. PubMed ID: 33466200
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial.
Zhao AM; Qiu WR; Mao LJ; Ren JG; Xu L; Yao MJ; Bilinksi K; Chang D; Liu JX
Trials; 2018 May; 19(1):275. PubMed ID: 29747670
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of herbal medicine for acute intracerebral hemorrhage (CRRICH): a multicentre randomised controlled trial.
Zeng L; Tang G; Wang J; Zhong J; Xia Z; Li J; Chen G; Zhang Y; Luo S; Huang G; Zhao Q; Wan Y; Chen C; Zhu K; Qiao H; Wang J; Huang T; Liu X; Zhang Q; Lin R; Li H; Gong B; Chen X; Zhou Y; Wen Z; Guo J
BMJ Open; 2019 May; 9(5):e024932. PubMed ID: 31076468
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Marquez-Romero JM; Arauz A; Ruiz-Sandoval JL; Cruz-Estrada Ede L; Huerta-Franco MR; Aguayo-Leytte G; Ruiz-Franco A; Silos H
Trials; 2013 Mar; 14():77. PubMed ID: 23510124
[TBL] [Abstract][Full Text] [Related]
5. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.
Chen CL; Young SH; Gan HH; Singh R; Lao AY; Baroque AC; Chang HM; Hiyadan JH; Chua CL; Advincula JM; Muengtaweepongsa S; Chan BP; de Silva HA; Towanabut S; Suwanwela NC; Poungvarin N; Chankrachang S; Wong KS; Eow GB; Navarro JC; Venketasubramanian N; Lee CF; Bousser MG;
Stroke; 2013 Aug; 44(8):2093-100. PubMed ID: 23780952
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.
Li B; Wang Y; Lu J; Liu J; Yuan Y; Yu Y; Wang P; Zhao X; Wang Z
Trials; 2015 Dec; 16():561. PubMed ID: 26654631
[TBL] [Abstract][Full Text] [Related]
7. Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.
Cooperative Group for Reassessment of Defibrase
Chin Med Sci J; 2005 Sep; 20(3):151-8. PubMed ID: 16261883
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.
Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R
CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177
[TBL] [Abstract][Full Text] [Related]
10. [Effect of blood activating stasis removing method on prognosis of intracerebral hemorrhage patients].
Yuan LX; Chen C; Zhang GM; Zhou L; Chen Y; Cui FY; Gao Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Feb; 35(2):174-8. PubMed ID: 25881461
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness of Qilong capsule in patients with ischemic stroke: A prospective, multicenter, non-randomized controlled trial.
Lyu J; Gao Y; Wei R; Cai Y; Shen X; Zhao D; Zhao X; Xie Y; Yu H; Chai Y; Xie Y
Phytomedicine; 2022 Sep; 104():154278. PubMed ID: 35780589
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study).
Venketasubramanian N; Chen CL; Gan RN; Chan BP; Chang HM; Tan SB; Picard D; Navarro JC; Baroque AC; Poungvarin N; Donnan GA; Bousser MG;
Int J Stroke; 2009 Feb; 4(1):54-60. PubMed ID: 19236501
[TBL] [Abstract][Full Text] [Related]
13. Clinical re-evaluation of removing blood stasis therapy in treating acute intracerebral hemorrhage safety and efficacy: a protocol for a randomized, controlled, multicenter study (CRRICH Trial).
Zeng L; Guo J; Wang J; Zhang Q; Li H; Lin R
Springerplus; 2016; 5(1):1466. PubMed ID: 27652041
[TBL] [Abstract][Full Text] [Related]
14. Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: A multi-center prospective randomized open-label blinded-endpoint trial.
Li JY; Yuan LX; Zhang GM; Zhou L; Gao Y; Li QB; Chen C
Chin J Integr Med; 2016 May; 22(5):328-34. PubMed ID: 27338955
[TBL] [Abstract][Full Text] [Related]
15. Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST).
Steiner T; Vincent C; Morris S; Davis S; Vallejo-Torres L; Christensen MC
J Stroke Cerebrovasc Dis; 2011; 20(4):287-94. PubMed ID: 20452785
[TBL] [Abstract][Full Text] [Related]
16. The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.
Meretoja A; Churilov L; Campbell BC; Aviv RI; Yassi N; Barras C; Mitchell P; Yan B; Nandurkar H; Bladin C; Wijeratne T; Spratt NJ; Jannes J; Sturm J; Rupasinghe J; Zavala J; Lee A; Kleinig T; Markus R; Delcourt C; Mahant N; Parsons MW; Levi C; Anderson CS; Donnan GA; Davis SM
Int J Stroke; 2014 Jun; 9(4):519-24. PubMed ID: 23981692
[TBL] [Abstract][Full Text] [Related]
17. Binafuxi granules in the treatment of common cold with heat syndrome based on traditional Uighur medicine: study protocol for a multicenter randomized controlled trial.
Min J; She B; Zhang X; Mao B; Chen Y
Trials; 2019 Mar; 20(1):187. PubMed ID: 30922355
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of GABA
Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
[TBL] [Abstract][Full Text] [Related]
19. Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial.
Naidech AM; Grotta J; Elm J; Janis S; Dowlatshahi D; Toyoda K; Steiner T; Mayer SA; Khanolkar P; Denlinger J; Audebert HJ; Molina C; Khatri P; Sprigg N; Vagal A; Broderick JP
Int J Stroke; 2022 Aug; 17(7):806-809. PubMed ID: 34427473
[TBL] [Abstract][Full Text] [Related]
20. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
Clark WM; Albers GW; Madden KP; Hamilton S
Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
